Figure 3
From: FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy
Cause-specific survival in all patients according to FDG-PET metabolic response.
Figure 3 | British Journal of Cancer
From: FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy
Cause-specific survival in all patients according to FDG-PET metabolic response.
